Abstract
Molecular biology brings to neuroscience the ability to clone receptors and design drugs to fit them. How quickly will ligand screens translate into products and profits?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Knight, P. Neurobiotech: Issues, No Answers. Nat Biotechnol 7, 1009–1012 (1989). https://doi.org/10.1038/nbt1089-1009
Issue Date:
DOI: https://doi.org/10.1038/nbt1089-1009